Jim Dennis

Title: Jim Dennis: Innovator in Glycan Research

Introduction

Jim Dennis is a notable inventor based in Etobicoke, Canada. He has made significant contributions to the field of glycan research, particularly in the regulation of receptor clustering. His innovative work has led to the development of a patent that addresses important biological processes.

Latest Patents

Jim Dennis holds a patent for "Compositions and methods for regulating receptor clustering." This invention relates to isolated complexes that comprise one or more galectins associated with Mgat5 modified glycans or polylactosamine modified glycans. The patent also includes isolated lectin-Mgat5 modified glycan lattices that feature an array of multivalent interactions among lectins, Mgat5 modified glycans, polylactosamine modified glycans, and/or glycoproteins. Additionally, the patent outlines methods for evaluating a test compound's ability to regulate receptor clustering through glycans on cell surfaces. It also describes methods for regulating receptor clustering on cell surfaces by altering glycans associated with receptor clustering.

Career Highlights

Jim Dennis is affiliated with Mount Sinai Hospital Corporation, where he applies his expertise in glycan research. His work has implications for understanding cellular interactions and could lead to advancements in therapeutic strategies.

Collaborations

Jim collaborates with Michael Demetriou, a fellow researcher in the field. Their combined efforts contribute to the advancement of knowledge in glycan-related processes.

Conclusion

Jim Dennis is a pioneering inventor whose work in glycan research has led to valuable patents and collaborations. His contributions are essential for advancing our understanding of receptor clustering and its implications in biology.